By staff writers

November 29, 2017 -- MR-guided focused ultrasound (MRgFUS) developer InSightec has received clearance from Taiwan's Food and Drug Administration for its Exablate Neuro system for treating essential tremor in patients who do not respond to medication.

Exablate Neuro uses focused ultrasound waves to target and ablate tissue deep within the brain with no incisions. The clearance was based on data from a randomized, double-blind clinical study conducted in eight medical centers in North America and Asia. The study demonstrated the safety and efficacy of noninvasive thalamotomy with Exablate Neuro.

Exablate Neuro also has been cleared in Japan, Korea, the U.S., Canada, Europe, and Israel.

Copyright © 2017

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking